nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP2D6—Fingolimod—multiple sclerosis	0.116	0.261	CbGbCtD
Rotigotine—CYP3A4—Fingolimod—multiple sclerosis	0.074	0.166	CbGbCtD
Rotigotine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0477	0.107	CbGbCtD
Rotigotine—CYP3A4—Triamcinolone—multiple sclerosis	0.0361	0.0811	CbGbCtD
Rotigotine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0348	0.078	CbGbCtD
Rotigotine—CYP3A4—Betamethasone—multiple sclerosis	0.031	0.0696	CbGbCtD
Rotigotine—CYP3A4—Prednisolone—multiple sclerosis	0.0306	0.0686	CbGbCtD
Rotigotine—CYP3A4—Prednisone—multiple sclerosis	0.0289	0.0648	CbGbCtD
Rotigotine—CYP2D6—Dexamethasone—multiple sclerosis	0.0284	0.0636	CbGbCtD
Rotigotine—CYP3A4—Dexamethasone—multiple sclerosis	0.018	0.0405	CbGbCtD
Rotigotine—DRD1—nerve—multiple sclerosis	0.00517	0.128	CbGeAlD
Rotigotine—DRD2—nerve—multiple sclerosis	0.00305	0.0754	CbGeAlD
Rotigotine—DRD1—brainstem—multiple sclerosis	0.00222	0.0548	CbGeAlD
Rotigotine—DRD4—brain—multiple sclerosis	0.00177	0.0436	CbGeAlD
Rotigotine—DRD3—nervous system—multiple sclerosis	0.00162	0.0401	CbGeAlD
Rotigotine—DRD3—central nervous system—multiple sclerosis	0.00156	0.0386	CbGeAlD
Rotigotine—DRD5—nervous system—multiple sclerosis	0.00152	0.0376	CbGeAlD
Rotigotine—DRD5—central nervous system—multiple sclerosis	0.00146	0.0362	CbGeAlD
Rotigotine—HTR1A—brainstem—multiple sclerosis	0.00145	0.0358	CbGeAlD
Rotigotine—DRD1—midbrain—multiple sclerosis	0.00141	0.0349	CbGeAlD
Rotigotine—DRD2—brainstem—multiple sclerosis	0.00131	0.0324	CbGeAlD
Rotigotine—DRD2—retina—multiple sclerosis	0.00126	0.0312	CbGeAlD
Rotigotine—DRD3—brain—multiple sclerosis	0.00124	0.0306	CbGeAlD
Rotigotine—DRD5—brain—multiple sclerosis	0.00116	0.0287	CbGeAlD
Rotigotine—DRD1—nervous system—multiple sclerosis	0.00116	0.0287	CbGeAlD
Rotigotine—DRD1—central nervous system—multiple sclerosis	0.00112	0.0276	CbGeAlD
Rotigotine—HTR1A—midbrain—multiple sclerosis	0.000925	0.0228	CbGeAlD
Rotigotine—HTR1A—spinal cord—multiple sclerosis	0.000902	0.0223	CbGeAlD
Rotigotine—DRD1—brain—multiple sclerosis	0.000889	0.0219	CbGeAlD
Rotigotine—DRD2—midbrain—multiple sclerosis	0.000835	0.0206	CbGeAlD
Rotigotine—CYP2D6—brainstem—multiple sclerosis	0.000788	0.0195	CbGeAlD
Rotigotine—HTR1A—nervous system—multiple sclerosis	0.00076	0.0188	CbGeAlD
Rotigotine—HTR1A—central nervous system—multiple sclerosis	0.000732	0.0181	CbGeAlD
Rotigotine—HTR1A—cerebellum—multiple sclerosis	0.000715	0.0177	CbGeAlD
Rotigotine—DRD2—nervous system—multiple sclerosis	0.000687	0.017	CbGeAlD
Rotigotine—DRD2—central nervous system—multiple sclerosis	0.000661	0.0163	CbGeAlD
Rotigotine—DRD2—cerebellum—multiple sclerosis	0.000646	0.016	CbGeAlD
Rotigotine—HTR1A—brain—multiple sclerosis	0.000581	0.0143	CbGeAlD
Rotigotine—Angioedema—Triamcinolone—multiple sclerosis	0.000581	0.00163	CcSEcCtD
Rotigotine—Angioedema—Methylprednisolone—multiple sclerosis	0.000579	0.00163	CcSEcCtD
Rotigotine—Erythema—Betamethasone—multiple sclerosis	0.000577	0.00162	CcSEcCtD
Rotigotine—Erythema—Dexamethasone—multiple sclerosis	0.000577	0.00162	CcSEcCtD
Rotigotine—Hallucination—Prednisone—multiple sclerosis	0.000574	0.00161	CcSEcCtD
Rotigotine—Malaise—Triamcinolone—multiple sclerosis	0.000573	0.00161	CcSEcCtD
Rotigotine—Malaise—Methylprednisolone—multiple sclerosis	0.000572	0.00161	CcSEcCtD
Rotigotine—Vertigo—Triamcinolone—multiple sclerosis	0.000571	0.00161	CcSEcCtD
Rotigotine—Syncope—Triamcinolone—multiple sclerosis	0.00057	0.0016	CcSEcCtD
Rotigotine—Vertigo—Methylprednisolone—multiple sclerosis	0.00057	0.0016	CcSEcCtD
Rotigotine—Syncope—Methylprednisolone—multiple sclerosis	0.000569	0.0016	CcSEcCtD
Rotigotine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000567	0.00159	CcSEcCtD
Rotigotine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000566	0.00159	CcSEcCtD
Rotigotine—Dizziness—Azathioprine—multiple sclerosis	0.000562	0.00158	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00056	0.00157	CcSEcCtD
Rotigotine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000558	0.00157	CcSEcCtD
Rotigotine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000557	0.00157	CcSEcCtD
Rotigotine—Shock—Prednisolone—multiple sclerosis	0.000555	0.00156	CcSEcCtD
Rotigotine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000555	0.00156	CcSEcCtD
Rotigotine—Cough—Triamcinolone—multiple sclerosis	0.000554	0.00156	CcSEcCtD
Rotigotine—Hypertension—Triamcinolone—multiple sclerosis	0.000549	0.00154	CcSEcCtD
Rotigotine—Hypertension—Methylprednisolone—multiple sclerosis	0.000547	0.00154	CcSEcCtD
Rotigotine—Urticaria—Mitoxantrone—multiple sclerosis	0.000546	0.00154	CcSEcCtD
Rotigotine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000545	0.00153	CcSEcCtD
Rotigotine—Vomiting—Azathioprine—multiple sclerosis	0.000541	0.00152	CcSEcCtD
Rotigotine—Arthralgia—Methylprednisolone—multiple sclerosis	0.00054	0.00152	CcSEcCtD
Rotigotine—Infestation NOS—Methotrexate—multiple sclerosis	0.000537	0.00151	CcSEcCtD
Rotigotine—Infestation—Methotrexate—multiple sclerosis	0.000537	0.00151	CcSEcCtD
Rotigotine—Rash—Azathioprine—multiple sclerosis	0.000536	0.00151	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000536	0.00151	CcSEcCtD
Rotigotine—Dermatitis—Azathioprine—multiple sclerosis	0.000536	0.00151	CcSEcCtD
Rotigotine—Depression—Methotrexate—multiple sclerosis	0.000535	0.00151	CcSEcCtD
Rotigotine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000535	0.0015	CcSEcCtD
Rotigotine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000535	0.0015	CcSEcCtD
Rotigotine—Discomfort—Triamcinolone—multiple sclerosis	0.000534	0.0015	CcSEcCtD
Rotigotine—Discomfort—Methylprednisolone—multiple sclerosis	0.000533	0.0015	CcSEcCtD
Rotigotine—Headache—Azathioprine—multiple sclerosis	0.000533	0.0015	CcSEcCtD
Rotigotine—Dry mouth—Triamcinolone—multiple sclerosis	0.000529	0.00149	CcSEcCtD
Rotigotine—Angioedema—Dexamethasone—multiple sclerosis	0.000527	0.00148	CcSEcCtD
Rotigotine—Angioedema—Betamethasone—multiple sclerosis	0.000527	0.00148	CcSEcCtD
Rotigotine—DRD2—brain—multiple sclerosis	0.000525	0.013	CbGeAlD
Rotigotine—Angiopathy—Prednisone—multiple sclerosis	0.000523	0.00147	CcSEcCtD
Rotigotine—Confusional state—Methylprednisolone—multiple sclerosis	0.000522	0.00147	CcSEcCtD
Rotigotine—Immune system disorder—Prednisone—multiple sclerosis	0.000521	0.00147	CcSEcCtD
Rotigotine—Malaise—Dexamethasone—multiple sclerosis	0.00052	0.00146	CcSEcCtD
Rotigotine—Malaise—Betamethasone—multiple sclerosis	0.00052	0.00146	CcSEcCtD
Rotigotine—Vertigo—Betamethasone—multiple sclerosis	0.000518	0.00146	CcSEcCtD
Rotigotine—Vertigo—Dexamethasone—multiple sclerosis	0.000518	0.00146	CcSEcCtD
Rotigotine—Syncope—Betamethasone—multiple sclerosis	0.000517	0.00145	CcSEcCtD
Rotigotine—Syncope—Dexamethasone—multiple sclerosis	0.000517	0.00145	CcSEcCtD
Rotigotine—Infection—Triamcinolone—multiple sclerosis	0.000515	0.00145	CcSEcCtD
Rotigotine—Infection—Methylprednisolone—multiple sclerosis	0.000514	0.00145	CcSEcCtD
Rotigotine—Shock—Triamcinolone—multiple sclerosis	0.00051	0.00144	CcSEcCtD
Rotigotine—Insomnia—Prednisolone—multiple sclerosis	0.00051	0.00143	CcSEcCtD
Rotigotine—Shock—Methylprednisolone—multiple sclerosis	0.000509	0.00143	CcSEcCtD
Rotigotine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000507	0.00143	CcSEcCtD
Rotigotine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000507	0.00143	CcSEcCtD
Rotigotine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000507	0.00143	CcSEcCtD
Rotigotine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000506	0.00142	CcSEcCtD
Rotigotine—Paraesthesia—Prednisolone—multiple sclerosis	0.000506	0.00142	CcSEcCtD
Rotigotine—Mental disorder—Prednisone—multiple sclerosis	0.000505	0.00142	CcSEcCtD
Rotigotine—Nausea—Azathioprine—multiple sclerosis	0.000505	0.00142	CcSEcCtD
Rotigotine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000503	0.00141	CcSEcCtD
Rotigotine—Malnutrition—Prednisone—multiple sclerosis	0.000502	0.00141	CcSEcCtD
Rotigotine—Erythema—Prednisone—multiple sclerosis	0.000502	0.00141	CcSEcCtD
Rotigotine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000501	0.00141	CcSEcCtD
Rotigotine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.0005	0.00141	CcSEcCtD
Rotigotine—Hypertension—Betamethasone—multiple sclerosis	0.000498	0.0014	CcSEcCtD
Rotigotine—Hypertension—Dexamethasone—multiple sclerosis	0.000498	0.0014	CcSEcCtD
Rotigotine—Asthenia—Mitoxantrone—multiple sclerosis	0.000493	0.00139	CcSEcCtD
Rotigotine—Discomfort—Dexamethasone—multiple sclerosis	0.000485	0.00136	CcSEcCtD
Rotigotine—Discomfort—Betamethasone—multiple sclerosis	0.000485	0.00136	CcSEcCtD
Rotigotine—Hypotension—Methylprednisolone—multiple sclerosis	0.000484	0.00136	CcSEcCtD
Rotigotine—Pain—Prednisolone—multiple sclerosis	0.000482	0.00136	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000472	0.00133	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000471	0.00133	CcSEcCtD
Rotigotine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00047	0.00132	CcSEcCtD
Rotigotine—Insomnia—Triamcinolone—multiple sclerosis	0.000469	0.00132	CcSEcCtD
Rotigotine—Insomnia—Methylprednisolone—multiple sclerosis	0.000468	0.00132	CcSEcCtD
Rotigotine—Infection—Dexamethasone—multiple sclerosis	0.000467	0.00131	CcSEcCtD
Rotigotine—Infection—Betamethasone—multiple sclerosis	0.000467	0.00131	CcSEcCtD
Rotigotine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000466	0.00131	CcSEcCtD
Rotigotine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000466	0.00131	CcSEcCtD
Rotigotine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000465	0.00131	CcSEcCtD
Rotigotine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000465	0.00131	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—multiple sclerosis	0.000465	0.00131	CcSEcCtD
Rotigotine—Shock—Dexamethasone—multiple sclerosis	0.000463	0.0013	CcSEcCtD
Rotigotine—Shock—Betamethasone—multiple sclerosis	0.000463	0.0013	CcSEcCtD
Rotigotine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000461	0.0013	CcSEcCtD
Rotigotine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000461	0.0013	CcSEcCtD
Rotigotine—Agitation—Prednisone—multiple sclerosis	0.000461	0.0013	CcSEcCtD
Rotigotine—Angioedema—Prednisone—multiple sclerosis	0.000459	0.00129	CcSEcCtD
Rotigotine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000456	0.00128	CcSEcCtD
Rotigotine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000455	0.00128	CcSEcCtD
Rotigotine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000455	0.00128	CcSEcCtD
Rotigotine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000455	0.00128	CcSEcCtD
Rotigotine—Malaise—Prednisone—multiple sclerosis	0.000453	0.00127	CcSEcCtD
Rotigotine—Vertigo—Prednisone—multiple sclerosis	0.000451	0.00127	CcSEcCtD
Rotigotine—Syncope—Prednisone—multiple sclerosis	0.00045	0.00127	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—multiple sclerosis	0.000449	0.00126	CcSEcCtD
Rotigotine—Anorexia—Dexamethasone—multiple sclerosis	0.000449	0.00126	CcSEcCtD
Rotigotine—Anorexia—Betamethasone—multiple sclerosis	0.000449	0.00126	CcSEcCtD
Rotigotine—Urticaria—Prednisolone—multiple sclerosis	0.000448	0.00126	CcSEcCtD
Rotigotine—Fatigue—Triamcinolone—multiple sclerosis	0.000447	0.00126	CcSEcCtD
Rotigotine—Fatigue—Methylprednisolone—multiple sclerosis	0.000446	0.00125	CcSEcCtD
Rotigotine—Pain—Triamcinolone—multiple sclerosis	0.000443	0.00125	CcSEcCtD
Rotigotine—Loss of consciousness—Prednisone—multiple sclerosis	0.000441	0.00124	CcSEcCtD
Rotigotine—Hypotension—Betamethasone—multiple sclerosis	0.00044	0.00124	CcSEcCtD
Rotigotine—Hypotension—Dexamethasone—multiple sclerosis	0.00044	0.00124	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—multiple sclerosis	0.000437	0.00123	CcSEcCtD
Rotigotine—Vomiting—Mitoxantrone—multiple sclerosis	0.000437	0.00123	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—multiple sclerosis	0.000435	0.00122	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000434	0.00122	CcSEcCtD
Rotigotine—Hypertension—Prednisone—multiple sclerosis	0.000433	0.00122	CcSEcCtD
Rotigotine—Rash—Mitoxantrone—multiple sclerosis	0.000433	0.00122	CcSEcCtD
Rotigotine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000433	0.00122	CcSEcCtD
Rotigotine—Headache—Mitoxantrone—multiple sclerosis	0.000431	0.00121	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000429	0.00121	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000429	0.00121	CcSEcCtD
Rotigotine—Arthralgia—Prednisone—multiple sclerosis	0.000427	0.0012	CcSEcCtD
Rotigotine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000427	0.0012	CcSEcCtD
Rotigotine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000426	0.0012	CcSEcCtD
Rotigotine—Insomnia—Betamethasone—multiple sclerosis	0.000426	0.0012	CcSEcCtD
Rotigotine—Insomnia—Dexamethasone—multiple sclerosis	0.000426	0.0012	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000425	0.00119	CcSEcCtD
Rotigotine—Paraesthesia—Betamethasone—multiple sclerosis	0.000423	0.00119	CcSEcCtD
Rotigotine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000423	0.00119	CcSEcCtD
Rotigotine—Discomfort—Prednisone—multiple sclerosis	0.000422	0.00119	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—multiple sclerosis	0.000422	0.00119	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—multiple sclerosis	0.00042	0.00118	CcSEcCtD
Rotigotine—Erythema—Methotrexate—multiple sclerosis	0.00042	0.00118	CcSEcCtD
Rotigotine—CYP3A4—nervous system—multiple sclerosis	0.000419	0.0104	CbGeAlD
Rotigotine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000415	0.00117	CcSEcCtD
Rotigotine—Dyspepsia—Betamethasone—multiple sclerosis	0.000414	0.00117	CcSEcCtD
Rotigotine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000414	0.00117	CcSEcCtD
Rotigotine—CYP2D6—nervous system—multiple sclerosis	0.000413	0.0102	CbGeAlD
Rotigotine—Urticaria—Triamcinolone—multiple sclerosis	0.000412	0.00116	CcSEcCtD
Rotigotine—Urticaria—Methylprednisolone—multiple sclerosis	0.000411	0.00116	CcSEcCtD
Rotigotine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000409	0.00115	CcSEcCtD
Rotigotine—Decreased appetite—Betamethasone—multiple sclerosis	0.000409	0.00115	CcSEcCtD
Rotigotine—Nausea—Mitoxantrone—multiple sclerosis	0.000408	0.00115	CcSEcCtD
Rotigotine—Infection—Prednisone—multiple sclerosis	0.000407	0.00115	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000406	0.00114	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000406	0.00114	CcSEcCtD
Rotigotine—Fatigue—Betamethasone—multiple sclerosis	0.000406	0.00114	CcSEcCtD
Rotigotine—Fatigue—Dexamethasone—multiple sclerosis	0.000406	0.00114	CcSEcCtD
Rotigotine—CYP3A4—central nervous system—multiple sclerosis	0.000404	0.00997	CbGeAlD
Rotigotine—Shock—Prednisone—multiple sclerosis	0.000403	0.00113	CcSEcCtD
Rotigotine—Pain—Betamethasone—multiple sclerosis	0.000402	0.00113	CcSEcCtD
Rotigotine—Pain—Dexamethasone—multiple sclerosis	0.000402	0.00113	CcSEcCtD
Rotigotine—Nervous system disorder—Prednisone—multiple sclerosis	0.000402	0.00113	CcSEcCtD
Rotigotine—Skin disorder—Prednisone—multiple sclerosis	0.000398	0.00112	CcSEcCtD
Rotigotine—CYP2D6—central nervous system—multiple sclerosis	0.000397	0.00981	CbGeAlD
Rotigotine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000396	0.00111	CcSEcCtD
Rotigotine—Anorexia—Prednisone—multiple sclerosis	0.000391	0.0011	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000389	0.0011	CcSEcCtD
Rotigotine—CYP2D6—cerebellum—multiple sclerosis	0.000388	0.00959	CbGeAlD
Rotigotine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000388	0.00109	CcSEcCtD
Rotigotine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000388	0.00109	CcSEcCtD
Rotigotine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000382	0.00107	CcSEcCtD
Rotigotine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000381	0.00107	CcSEcCtD
Rotigotine—Malaise—Methotrexate—multiple sclerosis	0.000378	0.00106	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—multiple sclerosis	0.000377	0.00106	CcSEcCtD
Rotigotine—Urticaria—Betamethasone—multiple sclerosis	0.000374	0.00105	CcSEcCtD
Rotigotine—Urticaria—Dexamethasone—multiple sclerosis	0.000374	0.00105	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000373	0.00105	CcSEcCtD
Rotigotine—Dizziness—Prednisolone—multiple sclerosis	0.000373	0.00105	CcSEcCtD
Rotigotine—Asthenia—Triamcinolone—multiple sclerosis	0.000372	0.00105	CcSEcCtD
Rotigotine—Asthenia—Methylprednisolone—multiple sclerosis	0.000371	0.00104	CcSEcCtD
Rotigotine—Insomnia—Prednisone—multiple sclerosis	0.000371	0.00104	CcSEcCtD
Rotigotine—Paraesthesia—Prednisone—multiple sclerosis	0.000368	0.00104	CcSEcCtD
Rotigotine—Pruritus—Triamcinolone—multiple sclerosis	0.000367	0.00103	CcSEcCtD
Rotigotine—Cough—Methotrexate—multiple sclerosis	0.000366	0.00103	CcSEcCtD
Rotigotine—Pruritus—Methylprednisolone—multiple sclerosis	0.000366	0.00103	CcSEcCtD
Rotigotine—Dyspepsia—Prednisone—multiple sclerosis	0.000361	0.00101	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—multiple sclerosis	0.000357	0.001	CcSEcCtD
Rotigotine—Decreased appetite—Prednisone—multiple sclerosis	0.000356	0.001	CcSEcCtD
Rotigotine—Rash—Prednisolone—multiple sclerosis	0.000356	0.001	CcSEcCtD
Rotigotine—Dermatitis—Prednisolone—multiple sclerosis	0.000355	0.000999	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000355	0.000998	CcSEcCtD
Rotigotine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000354	0.000996	CcSEcCtD
Rotigotine—Fatigue—Prednisone—multiple sclerosis	0.000353	0.000994	CcSEcCtD
Rotigotine—Headache—Prednisolone—multiple sclerosis	0.000353	0.000994	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—multiple sclerosis	0.000353	0.000993	CcSEcCtD
Rotigotine—Constipation—Prednisone—multiple sclerosis	0.00035	0.000986	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—multiple sclerosis	0.000345	0.000971	CcSEcCtD
Rotigotine—Dizziness—Triamcinolone—multiple sclerosis	0.000343	0.000965	CcSEcCtD
Rotigotine—Dizziness—Methylprednisolone—multiple sclerosis	0.000342	0.000962	CcSEcCtD
Rotigotine—Infection—Methotrexate—multiple sclerosis	0.00034	0.000957	CcSEcCtD
Rotigotine—Feeling abnormal—Prednisone—multiple sclerosis	0.000338	0.00095	CcSEcCtD
Rotigotine—Asthenia—Dexamethasone—multiple sclerosis	0.000338	0.00095	CcSEcCtD
Rotigotine—Asthenia—Betamethasone—multiple sclerosis	0.000338	0.00095	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000336	0.000945	CcSEcCtD
Rotigotine—Nausea—Prednisolone—multiple sclerosis	0.000335	0.000942	CcSEcCtD
Rotigotine—Pruritus—Betamethasone—multiple sclerosis	0.000333	0.000936	CcSEcCtD
Rotigotine—Pruritus—Dexamethasone—multiple sclerosis	0.000333	0.000936	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—multiple sclerosis	0.000333	0.000936	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000331	0.000931	CcSEcCtD
Rotigotine—Vomiting—Triamcinolone—multiple sclerosis	0.00033	0.000927	CcSEcCtD
Rotigotine—Vomiting—Methylprednisolone—multiple sclerosis	0.000329	0.000925	CcSEcCtD
Rotigotine—Rash—Triamcinolone—multiple sclerosis	0.000327	0.00092	CcSEcCtD
Rotigotine—Dermatitis—Triamcinolone—multiple sclerosis	0.000327	0.000919	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—multiple sclerosis	0.000326	0.000918	CcSEcCtD
Rotigotine—Rash—Methylprednisolone—multiple sclerosis	0.000326	0.000918	CcSEcCtD
Rotigotine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000326	0.000917	CcSEcCtD
Rotigotine—Urticaria—Prednisone—multiple sclerosis	0.000326	0.000916	CcSEcCtD
Rotigotine—Headache—Triamcinolone—multiple sclerosis	0.000325	0.000914	CcSEcCtD
Rotigotine—Headache—Methylprednisolone—multiple sclerosis	0.000324	0.000912	CcSEcCtD
Rotigotine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000322	0.000906	CcSEcCtD
Rotigotine—Diarrhoea—Betamethasone—multiple sclerosis	0.000322	0.000906	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—multiple sclerosis	0.00032	0.0009	CcSEcCtD
Rotigotine—CYP2D6—brain—multiple sclerosis	0.000315	0.00779	CbGeAlD
Rotigotine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000312	0.000878	CcSEcCtD
Rotigotine—Dizziness—Betamethasone—multiple sclerosis	0.000311	0.000875	CcSEcCtD
Rotigotine—Dizziness—Dexamethasone—multiple sclerosis	0.000311	0.000875	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—multiple sclerosis	0.00031	0.000871	CcSEcCtD
Rotigotine—Nausea—Triamcinolone—multiple sclerosis	0.000308	0.000866	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—multiple sclerosis	0.000308	0.000865	CcSEcCtD
Rotigotine—Nausea—Methylprednisolone—multiple sclerosis	0.000307	0.000865	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—multiple sclerosis	0.000304	0.000856	CcSEcCtD
Rotigotine—Hypersensitivity—Prednisone—multiple sclerosis	0.000302	0.000849	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—multiple sclerosis	0.000301	0.000848	CcSEcCtD
Rotigotine—Vomiting—Dexamethasone—multiple sclerosis	0.000299	0.000842	CcSEcCtD
Rotigotine—Vomiting—Betamethasone—multiple sclerosis	0.000299	0.000842	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—multiple sclerosis	0.000298	0.000837	CcSEcCtD
Rotigotine—Rash—Betamethasone—multiple sclerosis	0.000297	0.000835	CcSEcCtD
Rotigotine—Rash—Dexamethasone—multiple sclerosis	0.000297	0.000835	CcSEcCtD
Rotigotine—Dermatitis—Dexamethasone—multiple sclerosis	0.000296	0.000834	CcSEcCtD
Rotigotine—Dermatitis—Betamethasone—multiple sclerosis	0.000296	0.000834	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000296	0.000832	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—multiple sclerosis	0.000295	0.000831	CcSEcCtD
Rotigotine—Headache—Betamethasone—multiple sclerosis	0.000295	0.000829	CcSEcCtD
Rotigotine—Headache—Dexamethasone—multiple sclerosis	0.000295	0.000829	CcSEcCtD
Rotigotine—Asthenia—Prednisone—multiple sclerosis	0.000294	0.000827	CcSEcCtD
Rotigotine—Pain—Methotrexate—multiple sclerosis	0.000293	0.000824	CcSEcCtD
Rotigotine—Pruritus—Prednisone—multiple sclerosis	0.00029	0.000815	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000282	0.000794	CcSEcCtD
Rotigotine—Diarrhoea—Prednisone—multiple sclerosis	0.00028	0.000789	CcSEcCtD
Rotigotine—Nausea—Betamethasone—multiple sclerosis	0.000279	0.000786	CcSEcCtD
Rotigotine—Nausea—Dexamethasone—multiple sclerosis	0.000279	0.000786	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—multiple sclerosis	0.000272	0.000765	CcSEcCtD
Rotigotine—Dizziness—Prednisone—multiple sclerosis	0.000271	0.000762	CcSEcCtD
Rotigotine—Vomiting—Prednisone—multiple sclerosis	0.000261	0.000733	CcSEcCtD
Rotigotine—Rash—Prednisone—multiple sclerosis	0.000258	0.000727	CcSEcCtD
Rotigotine—Dermatitis—Prednisone—multiple sclerosis	0.000258	0.000726	CcSEcCtD
Rotigotine—Headache—Prednisone—multiple sclerosis	0.000257	0.000722	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000252	0.00071	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—multiple sclerosis	0.000246	0.000691	CcSEcCtD
Rotigotine—Nausea—Prednisone—multiple sclerosis	0.000243	0.000685	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—multiple sclerosis	0.000242	0.000682	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—multiple sclerosis	0.000234	0.000659	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—multiple sclerosis	0.000226	0.000637	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—multiple sclerosis	0.000218	0.000612	CcSEcCtD
Rotigotine—Rash—Methotrexate—multiple sclerosis	0.000216	0.000607	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—multiple sclerosis	0.000216	0.000607	CcSEcCtD
Rotigotine—Headache—Methotrexate—multiple sclerosis	0.000215	0.000603	CcSEcCtD
Rotigotine—Nausea—Methotrexate—multiple sclerosis	0.000203	0.000572	CcSEcCtD
Rotigotine—DRD1—Signaling Pathways—PGR—multiple sclerosis	5.67e-05	0.000358	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—IL2—multiple sclerosis	5.65e-05	0.000357	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—POMC—multiple sclerosis	5.64e-05	0.000356	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	5.63e-05	0.000355	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PGR—multiple sclerosis	5.59e-05	0.000353	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	5.58e-05	0.000353	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCR3—multiple sclerosis	5.56e-05	0.000351	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CNR1—multiple sclerosis	5.54e-05	0.00035	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	5.51e-05	0.000348	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CD28—multiple sclerosis	5.5e-05	0.000348	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	5.5e-05	0.000348	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCR3—multiple sclerosis	5.48e-05	0.000346	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	5.48e-05	0.000346	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	5.44e-05	0.000344	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CD28—multiple sclerosis	5.43e-05	0.000343	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCR2—multiple sclerosis	5.41e-05	0.000341	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	5.4e-05	0.000341	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	5.4e-05	0.000341	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—SPP1—multiple sclerosis	5.39e-05	0.00034	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCR2—multiple sclerosis	5.33e-05	0.000337	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	5.32e-05	0.000336	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—IL2—multiple sclerosis	5.29e-05	0.000334	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.28e-05	0.000333	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	5.25e-05	0.000332	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CCR5—multiple sclerosis	5.24e-05	0.000331	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	5.18e-05	0.000327	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL2RA—multiple sclerosis	5.17e-05	0.000326	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	5.14e-05	0.000325	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—IL2—multiple sclerosis	5.13e-05	0.000324	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	5.13e-05	0.000324	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—POMC—multiple sclerosis	5.12e-05	0.000323	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—POMC—multiple sclerosis	5.07e-05	0.00032	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	5.07e-05	0.00032	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	5.05e-05	0.000319	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—CCL2—multiple sclerosis	5.01e-05	0.000316	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—POMC—multiple sclerosis	5.01e-05	0.000316	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	5e-05	0.000316	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CXCL10—multiple sclerosis	4.99e-05	0.000315	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CNR1—multiple sclerosis	4.99e-05	0.000315	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	4.95e-05	0.000313	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	4.95e-05	0.000312	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	4.94e-05	0.000312	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GPC5—multiple sclerosis	4.94e-05	0.000312	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CNR1—multiple sclerosis	4.92e-05	0.000311	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	4.9e-05	0.00031	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	4.9e-05	0.00031	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PGR—multiple sclerosis	4.87e-05	0.000308	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	4.83e-05	0.000305	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—RRM1—multiple sclerosis	4.83e-05	0.000305	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	4.82e-05	0.000304	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	4.78e-05	0.000302	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—APOE—multiple sclerosis	4.77e-05	0.000301	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CD28—multiple sclerosis	4.73e-05	0.000299	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	4.65e-05	0.000294	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—POMC—multiple sclerosis	4.61e-05	0.000291	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—TYK2—multiple sclerosis	4.55e-05	0.000287	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—POMC—multiple sclerosis	4.55e-05	0.000287	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	4.52e-05	0.000285	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCL3—multiple sclerosis	4.51e-05	0.000285	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—CCL2—multiple sclerosis	4.51e-05	0.000285	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCL10—multiple sclerosis	4.49e-05	0.000284	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	4.45e-05	0.000281	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—CCL2—multiple sclerosis	4.45e-05	0.000281	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	4.44e-05	0.000281	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCL10—multiple sclerosis	4.43e-05	0.00028	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	4.39e-05	0.000277	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	4.36e-05	0.000276	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CD86—multiple sclerosis	4.36e-05	0.000276	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	4.34e-05	0.000274	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CD80—multiple sclerosis	4.31e-05	0.000272	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCL5—multiple sclerosis	4.3e-05	0.000271	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	4.29e-05	0.000271	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PGR—multiple sclerosis	4.28e-05	0.00027	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	4.2e-05	0.000265	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—IL2—multiple sclerosis	4.17e-05	0.000263	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.17e-05	0.000263	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.17e-05	0.000263	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CD28—multiple sclerosis	4.16e-05	0.000262	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	4.13e-05	0.00026	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	4.11e-05	0.000259	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—POMC—multiple sclerosis	4.1e-05	0.000259	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—TYK2—multiple sclerosis	4.09e-05	0.000259	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—RRM1—multiple sclerosis	4.09e-05	0.000258	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCR2—multiple sclerosis	4.08e-05	0.000258	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	4.05e-05	0.000255	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—TYK2—multiple sclerosis	4.04e-05	0.000255	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	4.02e-05	0.000254	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CCL2—multiple sclerosis	4.01e-05	0.000253	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	4e-05	0.000253	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SPP1—multiple sclerosis	3.98e-05	0.000251	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	3.96e-05	0.00025	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CD86—multiple sclerosis	3.93e-05	0.000248	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—MAPK1—multiple sclerosis	3.92e-05	0.000248	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	3.88e-05	0.000245	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CD86—multiple sclerosis	3.88e-05	0.000245	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCR5—multiple sclerosis	3.87e-05	0.000244	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCL5—multiple sclerosis	3.87e-05	0.000244	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	3.86e-05	0.000244	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	3.83e-05	0.000242	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCL5—multiple sclerosis	3.82e-05	0.000241	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL2RA—multiple sclerosis	3.81e-05	0.000241	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.81e-05	0.000241	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL2—multiple sclerosis	3.78e-05	0.000239	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CNR1—multiple sclerosis	3.77e-05	0.000238	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—IL2—multiple sclerosis	3.75e-05	0.000237	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—IL2—multiple sclerosis	3.7e-05	0.000234	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	3.65e-05	0.00023	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TYK2—multiple sclerosis	3.64e-05	0.00023	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SPP1—multiple sclerosis	3.58e-05	0.000226	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SPP1—multiple sclerosis	3.53e-05	0.000223	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	3.52e-05	0.000222	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—APOE—multiple sclerosis	3.52e-05	0.000222	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	3.5e-05	0.000221	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCR5—multiple sclerosis	3.48e-05	0.00022	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—POMC—multiple sclerosis	3.48e-05	0.00022	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	3.44e-05	0.000218	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCR5—multiple sclerosis	3.44e-05	0.000217	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL2RA—multiple sclerosis	3.43e-05	0.000217	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL2—multiple sclerosis	3.41e-05	0.000215	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	3.4e-05	0.000215	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	3.39e-05	0.000214	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2RA—multiple sclerosis	3.39e-05	0.000214	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CD86—multiple sclerosis	3.38e-05	0.000213	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL2—multiple sclerosis	3.36e-05	0.000212	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	3.34e-05	0.000211	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	3.32e-05	0.00021	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	3.23e-05	0.000204	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	3.19e-05	0.000201	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CD80—multiple sclerosis	3.18e-05	0.000201	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.18e-05	0.000201	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—APOE—multiple sclerosis	3.17e-05	0.0002	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.16e-05	0.000199	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—APOE—multiple sclerosis	3.13e-05	0.000197	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	3.1e-05	0.000196	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	3.09e-05	0.000195	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	3.08e-05	0.000194	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	3.06e-05	0.000193	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	3.03e-05	0.000192	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL2—multiple sclerosis	3.03e-05	0.000191	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—POMC—multiple sclerosis	3.02e-05	0.000191	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—IL6—multiple sclerosis	3.01e-05	0.00019	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	3e-05	0.000189	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CD86—multiple sclerosis	2.97e-05	0.000187	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCL2—multiple sclerosis	2.96e-05	0.000187	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	2.95e-05	0.000186	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	2.93e-05	0.000185	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	2.92e-05	0.000184	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—MAPK1—multiple sclerosis	2.9e-05	0.000183	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MMP9—multiple sclerosis	2.87e-05	0.000181	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CD80—multiple sclerosis	2.87e-05	0.000181	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	2.83e-05	0.000179	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CD80—multiple sclerosis	2.83e-05	0.000179	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	2.82e-05	0.000178	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.77e-05	0.000175	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.73e-05	0.000172	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—APOE—multiple sclerosis	2.73e-05	0.000172	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—POMC—multiple sclerosis	2.72e-05	0.000172	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	2.7e-05	0.000171	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TYK2—multiple sclerosis	2.69e-05	0.00017	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—POMC—multiple sclerosis	2.69e-05	0.00017	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCL2—multiple sclerosis	2.66e-05	0.000168	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	2.63e-05	0.000166	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCL2—multiple sclerosis	2.63e-05	0.000166	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	2.61e-05	0.000165	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	2.59e-05	0.000164	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	2.57e-05	0.000162	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	2.57e-05	0.000162	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	2.55e-05	0.000161	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—STAT3—multiple sclerosis	2.55e-05	0.000161	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.49e-05	0.000157	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	2.46e-05	0.000156	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	2.43e-05	0.000153	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	2.42e-05	0.000153	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APOE—multiple sclerosis	2.39e-05	0.000151	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TYK2—multiple sclerosis	2.39e-05	0.000151	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	2.37e-05	0.00015	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MYC—multiple sclerosis	2.37e-05	0.00015	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TGFB1—multiple sclerosis	2.36e-05	0.000149	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.35e-05	0.000148	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	2.34e-05	0.000148	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	2.32e-05	0.000147	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MAPK1—multiple sclerosis	2.32e-05	0.000146	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	2.29e-05	0.000145	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	2.24e-05	0.000142	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL2—multiple sclerosis	2.24e-05	0.000141	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL6—multiple sclerosis	2.22e-05	0.00014	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CD80—multiple sclerosis	2.16e-05	0.000137	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	2.15e-05	0.000136	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—multiple sclerosis	2.12e-05	0.000134	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	2.08e-05	0.000131	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—POMC—multiple sclerosis	2.06e-05	0.00013	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL2—multiple sclerosis	2.01e-05	0.000127	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	2.01e-05	0.000127	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	2e-05	0.000126	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.99e-05	0.000125	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.98e-05	0.000125	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.97e-05	0.000124	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	1.9e-05	0.00012	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—multiple sclerosis	1.88e-05	0.000119	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	1.88e-05	0.000119	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.83e-05	0.000115	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.81e-05	0.000115	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	1.79e-05	0.000113	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	1.78e-05	0.000113	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—multiple sclerosis	1.78e-05	0.000112	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—multiple sclerosis	1.75e-05	0.00011	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	1.74e-05	0.00011	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	1.73e-05	0.000109	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	1.72e-05	0.000109	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	1.71e-05	0.000108	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	1.7e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	1.69e-05	0.000107	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	1.67e-05	0.000106	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.67e-05	0.000105	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	1.64e-05	0.000103	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—multiple sclerosis	1.57e-05	9.94e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	1.57e-05	9.91e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—multiple sclerosis	1.55e-05	9.81e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	1.55e-05	9.78e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	1.54e-05	9.72e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2—multiple sclerosis	1.52e-05	9.6e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	1.52e-05	9.59e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	1.51e-05	9.55e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	1.51e-05	9.53e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	1.46e-05	9.2e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	1.44e-05	9.08e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—POMC—multiple sclerosis	1.43e-05	9.06e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOE—multiple sclerosis	1.41e-05	8.93e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	1.4e-05	8.85e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	1.4e-05	8.83e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	1.37e-05	8.66e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	1.35e-05	8.55e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	1.35e-05	8.53e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	1.32e-05	8.36e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—multiple sclerosis	1.31e-05	8.3e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—multiple sclerosis	1.31e-05	8.26e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	1.28e-05	8.08e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—POMC—multiple sclerosis	1.21e-05	7.67e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—multiple sclerosis	1.19e-05	7.5e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	1.19e-05	7.49e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—multiple sclerosis	1.18e-05	7.47e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—multiple sclerosis	1.17e-05	7.37e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	1.16e-05	7.34e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—multiple sclerosis	1.11e-05	6.99e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOE—multiple sclerosis	1.09e-05	6.89e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	1.05e-05	6.65e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	1.02e-05	6.42e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—POMC—multiple sclerosis	9.37e-06	5.92e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—multiple sclerosis	8.93e-06	5.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—multiple sclerosis	8.55e-06	5.4e-05	CbGpPWpGaD
